
|Articles|October 1, 2004
- Volume 0 0
Gene Discovery May Unlock Key to Obesity Syndrome
Author(s)Susan Farley
Advertisement
Scientists in the United States, Great Britain, and Canada were able to identify the last of 8 genes known to contribute to Bardet-Biedl syndrome (BBS), a rare disorder that combines the common problems of obesity, learning difficulties, diabetes, and asthma. The researchers think that the gene, known as BBS3/ARL6, can be used to understand the other BBS proteins and what causes BBS and, by extension, obesity and other BBS-related problems.
Articles in this issue
over 21 years ago
Rural Pharmacy Chain Chooses ScriptPro Automationover 21 years ago
System Improves Productivity, Drug Verificationover 21 years ago
COMPOUNDING HOTLINEover 21 years ago
Cardinal Introduces PatientPAK 340Bover 21 years ago
Obesity Is an Addiction, Researchers Sayover 21 years ago
Scientists Seek to Understand How Fat Causes Cancerover 21 years ago
Government Plans Attack on Obesityover 21 years ago
Consuming Fruit, Not Fat, Staves Off Weight Gainover 21 years ago
Court Reviews the "Usefulness" of PharmacistsAdvertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
ADA 2026: Factors Associated With GLP-1 RA Nonresponse in T2D—and What Pharmacists Should Screen For
2
ADA 2026: Survodutide Cuts Visceral Fat and Normalizes Liver Fat in MASLD. Here's What the Data Mean for Metabolic Risk
3
ADA 2026: Optimized Inhaled Insulin Dosing Outperforms Subcutaneous Analogs for Postprandial Glucose in T1D
4
The Hidden Reimbursement Crisis in Medicare’s Drug Price Negotiation Program
5






































































































































